Which product is commonly used to replace multiple coagulation factors in bleeding due to liver disease?

Which product is commonly used to replace multiple coagulation factors in bleeding due to liver disease?

• A. Vitamin K
• B. Cryoprecipitate
• C. Platelets
• D. Fresh frozen plasma

Answer: (D)

Coagulation factors are largely produced by the liver, so liver disease causes a broad deficiency of many factors, not just one. Fresh frozen plasma provides a broad mix of coagulation factors (including fibrinogen and multiple procoagulant factors), making it the most effective option to rapidly replace multiple factors during bleeding. Vitamin K may help if there is true deficiency of vitamin K–dependent factors, but in liver failure the liver’s synthetic capacity is impaired, so correcting with vitamin K often doesn’t normalize coagulation. Cryoprecipitate concentrates fibrinogen and a few factors, and platelets address cell-based contributions to hemostasis, but neither fully replace the wide range of factors needed in liver disease like fresh frozen plasma does.

Coagulation factors are largely produced by the liver, so liver disease causes a broad deficiency of many factors, not just one. Fresh frozen plasma provides a broad mix of coagulation factors (including fibrinogen and multiple procoagulant factors), making it the most effective option to rapidly replace multiple factors during bleeding. Vitamin K may help if there is true deficiency of vitamin K–dependent factors, but in liver failure the liver’s synthetic capacity is impaired, so correcting with vitamin K often doesn’t normalize coagulation. Cryoprecipitate concentrates fibrinogen and a few factors, and platelets address cell-based contributions to hemostasis, but neither fully replace the wide range of factors needed in liver disease like fresh frozen plasma does.